Latest News
Freenome, Inc.
- New Products: Pillar Biosciences, Freenome, Parse Biosciences, Medicover Genetics, Geneoscopy
- Freenome SimpleScreen Lung
- Form 8K Freenome Inc For: 20 October By Investing.com
- Freenome Expands Personalized Cancer Detection Portfolio With Simplescreen Lung Test
- Freenome Inc. Q3FY26 Results: Release date set for November 10
- Freenome to Report Third Quarter 2026 Financial Results on November 10, 2026
- Freenome to report Q3 2026 financial results on November 10 with a follow-up conference call.
- Updated Freenome CRC Blood Test Detects 18.2% of Advanced Precancerous Lesions
- Which of Ginkgo Bioworks (NYSE:DNA), 10x Genomics (NASDAQ:TXG), Freenome (NASDAQ:FRNM) or bioAffinity Technologies (NASDAQ:BIAF) Is the Hardest Hit as Healthcare Growth and AI-Biology Names Slide?
- Abbott launches Freenome’s colorectal cancer screening test
- Abbott rolls out SimpleScreen colorectal cancer blood test developed by Freenome
- Freenome (FRNM) Stock Analysis Report | Financials & Insights
Headlines from the last 30 days, linking to the original publishers. See all market news →